Anosmia in dementia is associated with Lewy bodies rather than Alzheimer’s pathology
نویسنده
چکیده
Objectives—To assess olfactory function of patients with dementia. Odour detection ability is impaired in clinical Parkinson’s disease. Evidence of impaired detection in patients with clinically diagnosed Alzheimer’s disease is inconsistent. No studies of olfaction have been neuropathologically validated. Methods—The olfactory function of 92 patients with dementia and 94 controls was assessed using a simple bedside test as part of the Oxford Project To Investigate Memory and Ageing (OPTIMA). Neuropathological assessment was made of cortical Lewy bodies and substantia nigra (SN) cell counts and of Alzheimer’s disease in all 92 patients, 22 of whom had SN Lewy bodies and 43 of whom had only Alzheimer’s disease. Results—Patients with Lewy bodies were more likely to be anosmic than those with Alzheimer’s disease or controls. Patients with Alzheimer’s disease were not more likely to be anosmic than controls. Nor was anosmia associated with degree of neurofibrillary tangles, as assessed by Braak stage. Among subjects with Lewy bodies, overall cortical Lewy body scores and Lewy body density in the cingulate were higher in those who were anosmic. Consensus clinical criteria for dementia with Lewy bodies had a sensitivity of 64% and specificity of 89%. In the absence of definite Alzheimer’s disease, the criteria had sensitivity of 100%. In patients with definite Alzheimer’s disease, anosmia was slightly more sensitive (55%) than the consensus criteria (33%). However, the addition of anosmia to the consensus criteria did not improve their overall performance. Conclusion—Dementia with Lewy bodies is associated with impaired odour detection. Misdiagnosis may have accounted for some previous reports of impaired odour detection in Alzheimer’s disease. Simple but more sensitive tests of anosmia are required if they are to be clinically useful in identifying patients with dementia with Lewy bodies. (J Neurol Neurosurg Psychiatry 2001;70:739–743)
منابع مشابه
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
OBJECTIVES To assess olfactory function of patients with dementia. Odour detection ability is impaired in clinical Parkinson's disease. Evidence of impaired detection in patients with clinically diagnosed Alzheimer's disease is inconsistent. No studies of olfaction have been neuropathologically validated. METHODS The olfactory function of 92 patients with dementia and 94 controls was assessed...
متن کاملStructural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools.
Papers 727 Visual hallucinations in Parkinson’s disease: a review and phenomenological survey J Barnes, A S David 734 Prospective study of hallucinations and delusions in Parkinson’s disease S Holroyd, L Currie, G F Wooten 739 Anosmia in dementia is associated with Lewy bodies rather than Alzheimer’s pathology R H McShane, Z Nagy, M M Esiri, E King, C Joachim, N Sullivan, A D Smith 744 Use of 1...
متن کاملAnosmia is very common in the Lewy body variant of Alzheimer's disease.
BACKGROUND Olfactory abnormalities are reported in Alzheimer's disease and Parkinson's disease. Anosmia appears to be common in dementia with Lewy bodies but not in pure Alzheimer's disease. OBJECTIVE To determine whether anosmia improves discrimination between the Lewy body variant (LBV) of Alzheimer's disease and "pure" Alzheimer's disease. METHODS 106 cases of necropsy confirmed pure Alz...
متن کاملUptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The heart-tomediastinum ratio (H/M) in PD and DLB is significantly lower than that in Parkinson’s plus syndromes and Alzheimer’s disease. Although this ra...
متن کاملCsf T‐tau Is Associated with Shorter Survival in Dementia with Lewy Bodies E‐mail
Pathology typical for Dementia with Lewy bodies (DLB) has been demonstrated to increase mortality to a greater extent than Alzheimer’s disease (AD) pathology. However, mortality in DLB has also been shown to increase with concomitant AD pathology. Furthermore, in a recent publication, we showed that there is a robust and specific increase of CSF calcium and magnesium in DLB patients compared to...
متن کامل